Bacterial profiles and proteolytic activity in peri-implantitis versus healthy sites.

Peri-implantitis is a biofilm-induced destructive inflammatory process that, over time, results in loss of supporting bone around an osseointegrated dental implant. Biofilms at peri-implantitis sites have been reported to be dominated by Gram-negative anaerobic rods with a proteolytic metabolism such as, Fusobacterium, Porphyromonas, Prevotella and Tannerella, as well as anaerobic Gram-positive cocci. In this study, we hypothesized that protease activity is instrumental in driving bone destruction and we therefore compared the microbial composition and level of protease activity in samples of peri-implant biofluid (PIBF) from 25 healthy subjects (H group) and 25 subjects with peri-implantitis (PI group). Microbial composition was investigated using culture techniques and protease activity was determined using a FITC-labelled casein substrate. The microbial composition was highly variable in subjects both in the H and PI groups but one prominent difference was the prevalence of Porphyromonas/Prevotella and anaerobic Gram positive cocci which was significantly higher in the PI than in the H group. A subgroup of subjects with peri-implantitis displayed a high level of protease activity in the PIBF compared to healthy subjects. However, this activity could not be related to the presence of specific bacterial species. We propose that a high level of protease activity may be a predictive factor for disease progression in peri-implantitis. Further longitudinal studies are however required to determine whether assessment of protease activity could serve as a useful method to identify patients at risk for progressive tissue destruction.

Human endogenous peptide p33 inhibits detrimental effects of LL-37 on osteoblast viability.

BACKGROUND AND OBJECTIVE: High levels of the antimicrobial peptide, LL-37, are detected in gingival crevicular fluid from patients with chronic periodontitis. LL-37 not only shows antimicrobial activity but also affects host-cell viability. The objective of the present study was to identify endogenous mechanisms that antagonize the detrimental effects of LL-37 on osteoblast viability, focusing on the human peptide p33 expressed on the surface of various cell types. MATERIAL AND METHODS: Human osteoblast-like MG63 cells and human hFOB1.19 osteoblasts were treated with or without LL-37 in the presence or absence of p33. Recombinant human p33 was expressed in an Escherichia coli expression system. Lactate dehydrogenase (LDH) was assessed using an enzymatic spectrophotometric assay. DNA synthesis was determined by measuring [(3) H]-thymidine incorporation. Cell number was assessed by counting cells in a Bürker chamber. Intracellular Ca(2+) was monitored by recording Fluo 4-AM fluorescence using a laser scanning confocal microscope. Cellular expression of p33 was determined by western blotting. RESULTS: LL-37 caused a concentration-dependent release of LDH from human osteoblasts, showing a half-maximal response value (EC50 ) of 4 µm and a rapid and sustained rise in the intracellular Ca(2+) concentration of osteoblasts, suggesting that LL-37 forms pores in the cell membrane. p33 (10 µm) inhibited the LL-37-induced LDH release and LL-37-evoked rise in intracellular Ca(2+) concentration, suggesting that p33 prevents LL-37-induced permeabilization of the cell membrane. Moreover, p33 blocked LL-37-induced attenuation of osteoblast numbers. Also, mucin antagonized, at concentrations representative for nonstimulated whole saliva, LL-37-evoked LDH release, whilst cationic endogenous polyamines had no impact on LL-37-induced LDH release from osteoblasts. CONCLUSIONS: The endogenous peptide p33 prevents LL-37-induced reduction of human osteoblast viability. Importantly, this mechanism may protect the osteoblasts from LL-37-induced cell damage in patients suffering from chronic periodontitis associated with high levels of LL-37 locally.

Salivary proteins promote proteolytic activity in Streptococcus mitis biovar 2 and Streptococcus mutans.

A major function of the salivary pellicle on oral surfaces is to promote colonization of the commensal microbiota by providing binding sites for adherence. Streptococcus mitis is an early colonizer of the oral cavity whereas Streptococcus mutans represents a later colonizer. To survive and grow, oral bacteria produce enzymes, proteases and glycosidases, which allow them to exploit salivary proteins as a nutrient source. In this study, adherence and proteolytic activity of S. mitis biovar 2 and S. mutans were investigated in a flow-cell model in the presence of different populations of surface-associated salivary proteins. Streptococcus mitis biovar 2 adhered well to surfaces coated with both a MUC5B-enriched fraction and a pool of low-density proteins containing MUC7, amylase, cystatin, gp340, immunoglobulin A, lactoferrin, lysozyme and statherin, whereas adherence of S. mutans to these proteins was poor. In environments of MUC5B or the low-density proteins, both S. mitis biovar 2 and S. mutans showed high levels of proteolytic activity. For S. mitis in the MUC5B environment, most of this activity may be attributable to contact with the molecules in the fluid phase although activity was also enhanced by adherence to surface-associated MUC5B. These data suggest that although they differ in their capacity to adhere to surface-associated salivary proteins, in the natural environment exploitation of saliva as a nutrient source can contribute to survival and colonization of the oral cavity by both S. mitis biovar 2 and S. mutans.

Elevated levels of salivary lactoferrin, a marker for chronic periodontitis?

BACKGROUND AND OBJECTIVE: Whole saliva is a complex mixture of fluids essential for the well-being of the oral hard and soft tissues. Saliva contains numerous antimicrobial proteins that help protect the oral ecosystem from infectious agents. Chronic periodontitis is an infectious chronic inflammatory condition that affects the tooth-supporting structures and leads to their destruction. The aim of the present study was to investigate differences in concentrations of salivary lactoferrin in subjects with and without periodontal disease and correlate these values with clinical variables associated with periodontal disease. MATERIAL AND METHODS: Stimulated whole saliva was collected from 17 subjects with chronic periodontitis and 17 periodontally healthy control subjects. Data relating to bleeding on probing, probing pocket depth and horizontal bone loss were registered. Concentrations of lactoferrin, lysozyme and IgA in stimulated whole saliva were quantified using ELISA. RESULTS: Subjects with chronic periodontits showed higher concentrations of lactoferrin in stimulated whole saliva compared with periodontally healthy control subjects (p < 0.05). Salivary concentrations of lactoferrin were positively correlated with bleeding on probing (p < 0.001) and the number of sites with probing pocket depth ≥ 6 mm (p < 0.001). CONCLUSION: Lactoferrin is raised in stimulated whole saliva in subjects with chronic periodontitis and is correlated with probing pocket depth ≥ 6 mm.

Salivary gel-forming mucin MUC5B--a nutrient for dental plaque bacteria.

INTRODUCTION: Model systems with oral bacteria from dental plaque have demonstrated that the utilization of complex glycoproteins as a food source cannot be undertaken by single species but requires concerted degradation by a multi-species consortium, with each member contributing one or a few hydrolytic enzymes. Unlike previous studies, the aim of the present investigation was to explore the ability of fresh dental plaque to degrade salivary mucin, MUC5B, isolated by methods designed to retain intact the natural polymeric structure and physiological conformation, in an attempt to mimic the naturally occurring interaction between the oral microbiota and salivary mucins. METHODS: Human salivary MUC5B was isolated from whole saliva by density-gradient centrifugation and incubated with freshly isolated supragingival dental plaque with samples subjected to fluorescent staining for viability and metabolic activity. In addition, the degradation of MUC5B oligosaccharide side chains was studied using a lectin assay, recognizing three different carbohydrate epitopes commonly found on mucin oligosaccharide side chains. RESULTS: The addition of purified salivary MUC5B elicited a strong metabolic response from the biofilm cells, whereas individual strains of Streptococcus oralis and Streptococcus gordonii isolated from the same plaque were not able to utilize the MUC5B. The degradation of terminal saccharide moieties on the MUC5B was demonstrated by a marked decrease in both sialic acid and fucose reactivity. CONCLUSION: These results have shown that dental plaque is capable of utilizing human salivary MUC5B as a nutrient source, a process possibly requiring the synergistic degradation of the molecule by a consortium of oral bacteria in the plaque community.

Mucins MUC5B and MUC7 in minor salivary gland secretion of children and adults.

OBJECTIVE: The study was designed to investigate the relative amount of MUC5B and MUC7 in minor salivary glands in children and adults, in order to test the hypothesis that secretion of salivary mucins changes between childhood and adulthood. METHODS: Ninety individuals in the age-groups 3-year-olds, 14-year-olds, and young adults 20-25 year-olds were recruited. Sialopapers were applied on the labial and the buccal mucosa and then placed in the Periotron 8,000 (Proflow ) for calculation of the amount of saliva. The assessment of MUC5B and MUC7 was carried out in an ELISA using the LUM5B-2 and the LUM7-1 antiserum, respectively. RESULTS: MUC5B and MUC7 were detected in the labial minor gland saliva in all age groups. In buccal gland saliva, only a few individuals in each age group showed detectable amounts of the mucins. In the labial area, a significantly lower level of MUC7 was noted in 3-year-olds compared with adults. CONCLUSION: The results indicate a site-dependent difference in minor gland mucin secretion and an age-related difference in the labial gland secretion of MUC7.

New monoclonal antibodies to non-glycosylated domains of the secreted mucins MUC5B and MUC7.

The separation and characterization of salivary mucins is not straightforward because of their large size, heterogeneity, and molecular interactions. The MUC5B and MUC7 mucins are major glycoprotein components of saliva that are thought to play a vital role in maintaining oral health. MUC5B is also a major component of respiratory mucus and is produced by the tracheal and bronchial glands, while MUC7 has a more limited pattern of expression in the bronchial tree. MUC5B is a gel-forming mucin and thus confers viscosity, whereas MUC7 is much smaller. MUC7 has anti-fungal activity, and both mucins interact with bacteria. The aim of this work was to produce new monoclonal antibodies that can be used to quantify and characterize these mucins by standard laboratory procedures. Peptide sequences in non-conserved and non-glycosylated regions were selected and monoclonal antibodies produced by an efficient immunization and cloning strategy, and screening against purified mucins. Three new antibodies-EU-MUC5Ba and EU-MUC5Bb (against MUC5B) and EU-MUC7a (against MUC7)-were isolated that do not show cross-reactivity with other gel-forming mucins. All work on immunohistochemistry can be used for semi-quantitative immunoblotting after agarose gel electrophoresis. These reagents are valuable tools to study changes in these mucins in oral and respiratory disease, and unlike other monoclonal antibodies to these mucins they recognize epitopes that are not affected by glycosylation.

N-terminal cleavage of the salivary MUC5B mucin. Analogy with the Van Willebrand propolypeptide?

Sequence similarities between the oligomeric mucins (MUC2, MUC5AC, MUC5B) and the von Willebrand factor suggest that they may be assembled in a similar way. After oligomerization, a fragment corresponding to the D1 and D2 domains is released from the von Willebrand factor. This cleavage does not appear to occur in pig submaxillary mucin, the only mammalian mucin in which this cleavage has been examined thus far, but whether other oligomeric mucins undergo N terminus proteolysis is not known. Antibodies recognizing the D1, D2, D3, and the first Cys domains in MUC5B were established and used to investigate to what extent proteolytic cleavage occurs within the N-terminal part of salivary MUC5B. The antibodies against the D1 and D2 domains identified a polypeptide corresponding in size to a MUC5B fragment generated by cleavage within the D' domain analogously with the von Willebrand factor propolypeptide. The antibodies did not recognize the main mucin population, suggesting that the major part of salivary MUC5B is subjected to this cleavage. An antibody recognizing the D3 domain was used to reveal a second cleavage site in the "soluble" but not in the "insoluble" MUC5B fraction: the first structural difference observed between soluble and insoluble salivary MUC5B. The identification of these cleavage events shows that the N-terminal sites for MUC5B oligomerization are present in the D3 domain and/or in domains located C-terminal to this part of the molecule.

Macromolecular organization of saliva: identification of 'insoluble' MUC5B assemblies and non-mucin proteins in the gel phase.

Stimulated human submandibular/sublingual (HSMSL) and whole saliva were separated into sol and gel phases and mucins were isolated by density-gradient centrifugation in CsCl/4M guanidinium chloride. MUC5B and MUC7 were identified using anti-peptide antisera raised against sequences within the MUC5B and MUC7 apoproteins respectively. MUC7 was found mainly in the sol phase of both HSMSL and whole saliva, but some MUC7 was consistently present in the gel phase, suggesting that this mucin may interact with the salivary gel matrix. In HSMSL saliva, MUC5B was found in the gel phase; however, most of the material was 'insoluble' in guanidinium chloride and was only brought into solution by reduction. In whole saliva, the MUC5B mucin was present both in the sol and gel phases although some material was again 'insoluble'. Rate-zonal centrifugation of whole saliva showed that MUC5B mucins in the sol phase were smaller than those in the gel phase, suggesting differences in oligomerization and/or degradation. Antibodies against IgA, secretory component, lysozyme and lactoferrin were used to study the distribution of non-gel-forming proteins in the different phases of saliva. The majority of these proteins was found in the sol phase of both HSMSL and whole saliva. However, a significant fraction was present in the gel phase of whole saliva, suggesting a post-secretory interaction with the salivary gel matrix. A monoclonal antibody against a parotid salivary agglutinin was used to show that this protein is present mainly in the gel phase of both whole saliva and parotid secretion.

Sensitivity of Two Disjunct Bacterioplankton Communities to Exudates from the Cyanobacterium Microcystis aeruginosa Kützing.

Microcystis aeruginosa Kützing releases a variety of bioactive compounds during growth. This study determined whether bacteria from communities co-occurring (M+) or not (M-) with this cosmopolitan cyanobacterium respond similarly to its products. Fifty M+ bacteria from a M. aeruginosa bloom site (Western Basin of Lake Erie) and 50 M- bacteria from a Microcystis-free site (East Twin Lake, Portage Co., OH) were isolated and grown on Standard Methods Agar. Three levels of testing were performed: chemotaxis, antibiotic response, and 48-h cell abundance. Chemotaxis was compared using capillary tubes placed in contact with bacterial, Standard Methods Broth (SMB) suspensions. The capillary choices were conditioned SMB, M. aeruginosa exudate, and BG-11. M+ bacteria showed significantly greater (Tukey's test, p < 0.005) positive chemotaxis to M. aeruginosa exudate compared to control conditions and to M-strains. The latter showed a negative chemotactic response to M. aeruginosa exudate compared to control conditions. Antibiotic response was tested by sensitivity disk assays, first using M. aeruginosa exudates, whole cells, and homogenized cells, and then placing the disks on bacterial lawns of each strain. M+ bacteria were significantly more resistant to inhibition than M- bacteria (chi-square test, p < 0.01). M. aeruginosa exudate, BG-11 algal medium, SMB, and distilled water effects on 48-h abundance of the strains were compared. The M- community bacteria exhibited significantly lower growth yields (Tukey's comparison of means test, p < 0.005) in M. aeruginosa exudate than did the M+ strains. It is evident that those bacteria co-occurring with M. aeruginosa are more likely to be attracted to it, able to withstand exposure to it, and able to utilize its products without inhibition than are bacteria from communities without previous exposure to this cyanobacterium.

MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage.

Mucins from human whole saliva, as well as from respiratory- and cervical-tract secretions, were subjected to density-gradient centrifugation in CsCl/0.5 M guanidinium chloride. A polydisperse population of MUC5B mucins was demonstrated in all samples using anti-peptide antisera (LUM5B-2, LUM5B-3 and LUM5B-4) raised against sequences within the MUC5B mucin. The sequences recognized by the LUM5B-2 and LUM5B-3 antisera are located within the domains flanking the highly glycosylated regions of MUC5B, and reduction increased the reactivity with these antibodies, suggesting that the epitopes are partially shielded and that these regions are folded and stabilized by disulphide bonds. Rate-zonal centrifugation before and after reduction showed MUC5B to be a large oligomeric mucin composed of disulphide-linked subunits. In saliva and respiratory-tract secretions, populations of MUC5B mucins with different charge densities were identified by ion-exchange HPLC, suggesting the presence of MUC5B 'glycoforms'. In trachea, the F2 monoclonal antibody against the sulpho-Lewis C structure reacted preferentially with the later-to-be-eluted populations. An antibody (LUM5B-4) recognizing a sequence in the C-terminal domain of MUC5B identified, after reduction, the mucin subunits as well as smaller fragments, suggesting that some of the MUC5B mucins are cleaved within the C-terminal domain. Immunohistochemistry revealed that MUC5B is produced by cells dispersed throughout the human submandibular and sublingual glands, in the airway submucosal glands as well as the goblet cells, and in the epithelium and glands of the endocervix. The F2 antibody stained a subpopulation of the MUC5B-producing cells in the airway submucosal glands, suggesting that different cells may produce different glycoforms of MUC5B in this tissue.

Prevalence of diabetic retinopathy in children and adolescents with IDDM. A population-based multicentre study.

Vision-threatening diabetic retinopathy can be prevented if it is diagnosed before becoming too advanced. Since diabetic retinopathy has been reported to occur only rarely before the end of pubertal development, children and adolescents are seldom included in screening programmes. We invited 780 children and adolescents with insulin-dependent diabetes mellitus diagnosed before the age of 15.0 years (disease duration of < 12 years) and who were older than 9.0 years at the time of examination from eight regions of Sweden. Retinal examination was performed with stereoscopic fundus photograph. The photograph were rated according to a modified Airlie House classification. The dropouts (223/780, 28.6%) were significantly older and with a longer duration of diabetes than the examined children (p < 0.001 and 0.001, respectively). Photographs from 557 patients aged (median [interquartile range]:14.6 [12.4-17.0]) years and with a diabetes duration of 8.0 (5.5-9.9) years were evaluated. Retinopathy was demonstrated in 81 patients (14.5%):66 with background retinopathy, 2 with microaneurysms and hard exudates, 12 with preproliferative retinopathy, 1 with proliferative retinopathy. Preproliferative retinopathy was diagnosed in a 12.8-year-old girl in pubertal stage 3 and an 11.8-year-old boy in pubertal stage 2, and proliferative retinopathy was found in a 21.5-year-old girl. Retinopathy was demonstrated in 6% and 18% of patients in pubertal stages 1 and 5, respectively. The overall prevalence of retinopathy in this population may even be higher since the dropouts were older and had a longer duration of diabetes. Since background and preproliferative retinopathy were found in children before puberty, we recommend including children and adolescents in screening programmes for diabetic retinopathy from the age of 10 years.

Initial and long-term effects of metoprolol and timolol on the intraocular pressure. A comparison in healthy subjects.

The effect of 3% metoprolol and 0.5% timolol eye drops on the intraocular pressure (IOP) was compared in healthy subjects. The effect of a single dose was determined up to 48 h after administration of the drug before and after 2 weeks' treatment twice daily with the test drug. The study was performed as a randomized, double-masked cross-over study. Both drugs caused significant reductions in IOP with a maximal effect 2 to 8 h after administration of the drug. Timolol reduced the mean IOP from 14.8 to 10.7 mmHg after 2 h. The corresponding figures for metoprolol were 14.1 and 11.5 mmHg. There was no clear cut effect in the untreated eye for either drug. The effect of one drop timolol lasted for at least 48 h. The duration of one drop metoprolol was 36 h, but there was a marked reduction of the effect between 8 and 12 h after administration of the drug. Both drugs caused a smaller pressure reduction when the effect of one drop was followed for 48 h after to weeks' treatment compared to the initial response. This "escape" was of the same order for both drugs. It has been concluded that the composition of metoprolol eye drops used in the present study is less efficient than timolol as an ocular hypotensive agent.

Effects of systemic and topical administration of metoprolol on intraocular pressure in healthy subjects.

The effect of a single dose metoprolol tablets or eye drops on intraocular pressure (IOP), blood pressure and heart rate was determined in healthy volunteers. The ocular tolerance of 6 weeks treatment with 1% eye drops was also studied. A 100 mg tablet reduced IOP for least 10 h with a maximum effect after 4 h corresponding to 32% of the pre-treatment pressure. The effects of 25 and 50 mg tablets were less pronounced and of a shorter duration. No consistent effect on blood-pressure was obtained, but doses that reduced IOP also reduced heart rate. A short-lasting reduction in IOP was obtained with 0.5% eye drops, while 1, 3 and 5% all caused significant reductions lasting at least 10-12 h. IOP was reduced by 13, 20 and 27% 4 h after administration of 1, 3 and 5% eye drops, respectively. No effect was observed in the contralateral, untreated eye, and no cardiovascular effects were obtained after administration of the eye drops. 1% eye drops administered twice daily for 6 weeks caused no clinically significant side effect.

Response of thermal algal-bacterial mat to grazing by brine flies.

Gelatinous mats of blue-green algae (cyanobacteria) and bacteria in alkaline thermal springs of Yellowstone National Park add biomass at the surface more rapidly than material is degraded in the anaerobic layers underneath. This inequality leads to flow diversion and exposure of mat surface. The microenvironment of these cool exposed "islands" is drastically altered as adults and larvae of ephydrid fly species invade, feed on, and solubilize the mat. We studied the effect of this grazing by comparing hot and cool ungrazed controls with mat that was cooled and remained open to invasion by ephydrid flies. Mat community biomass changes (ash free dry weight-AFDW) and changes in bacterial numbers were determined. Mat biomass was essentially unchanged for 3 weeks in the controls. Numbers of bacteria remained unchanged in the cool ungrazed control but decreased by more than 90% in the hot-ungrazed control. Grazing by ephydrid flies initially increased both mat biomass and numbers of unicellular heterotrophic bacteria. When grazed mat was reexposed to flowing hot water, biomass and bacterial numbers per mg AFDW declined immediately and significantly. The long-term effect of grazing on the mat is solubilization with downstream biomass export and subsequent initiation of successional algal-bacterial mat regrowth. Our experimental results suggest an initial stimulation of net photosynthesis by grazing, possibly related to the promotion of bacterial activity resulting in the release of essential mineral nutrients and/or free CO2.

The effect of metoprolol on intra-ocular pressure in glaucoma. A pilot study.

Eleven patients with previously untreated glaucoma of one eye were given metoprolol, 50 mg x 3 for one day. Intraocular pressure (IOP) and heart rate were significantly reduced during treatment, and increased after withdrawal of the drug. In the eyes with glaucoma, the mean IOP was reduced from 30.1 to 20.6 mmHg during treatment. Systolic and diastolic blood pressures were also reduced during treatment, but stayed at the same level after withdrawal of the drug. It is concluded that at least part of the reductions observed for IOP and heart rate are drug-induced, while the effect on blood preassure is mainly induced by factors other than the drug. The effect on IOP is considered large enough to be of clinical interest.

Thermophilic ostracod: aquatic metazoan with the highest known temperature tolerance.

The upper lethal temperature for an ostracod of the genus Potamocypris collected from a thermal stream ranged from 49 degrees C for incubation of more than 5 hours to 55.75 degrees C for 1-minute incubations. Field collections were held at 35 degrees C for less than 24 hours before experimental incubations. Calculated temperatues for 50 percent mortality for 60, 40, 20, 10, 5, and 1 minute of exposure were 50.44 degrees , 50.96 degrees , 51.43 degrees , 52.03 degrees , 52.77 degrees , and 55.12 degrees C, respectively.